The global market for Anti Allergy Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti Allergy Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti Allergy Medicine by region & country, by Type, and by Application.

The Anti Allergy Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Allergy Medicine.

Market Segmentation

Scope of Anti Allergy Medicine - Market Report

Report Metric	Details
Report Name	Anti Allergy Medicine - Market
CAGR	5%
Segment by Type:	Antihistamines Anaphylaxis Mediator Blocker Drugs Calcium Drugs Immunosuppressant Drugs
Segment by Application	Online Pharmacy Hospital Offline Pharmacy Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Bayer Corp, Sanofi, Weefsel Pharma, Arlak Biotech, Hetero Healthcare, Pharma Franchise, Nutra Respiro, Aden Healthcare, Stallergenes Greer, GSK, Hikma Pharmaceuticals, Med Globe Therapeutics Limited, Taiho Pharmaceutical, Regeneron Pharmaceuticals, Glenmark
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti Allergy Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti Allergy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti Allergy Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti Allergy Medicine - Market report?

Ans: The main players in the Anti Allergy Medicine - Market are Johnson & Johnson, Bayer Corp, Sanofi, Weefsel Pharma, Arlak Biotech, Hetero Healthcare, Pharma Franchise, Nutra Respiro, Aden Healthcare, Stallergenes Greer, GSK, Hikma Pharmaceuticals, Med Globe Therapeutics Limited, Taiho Pharmaceutical, Regeneron Pharmaceuticals, Glenmark

What are the Application segmentation covered in the Anti Allergy Medicine - Market report?

Ans: The Applications covered in the Anti Allergy Medicine - Market report are Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Others

What are the Type segmentation covered in the Anti Allergy Medicine - Market report?

Ans: The Types covered in the Anti Allergy Medicine - Market report are Antihistamines, Anaphylaxis Mediator Blocker Drugs, Calcium Drugs, Immunosuppressant Drugs

1 Market Overview

1.1 Anti Allergy Medicine Product Introduction

1.2 Global Anti Allergy Medicine Market Size Forecast

1.2.1 Global Anti Allergy Medicine Sales Value (2019-2030)

1.2.2 Global Anti Allergy Medicine Sales Volume (2019-2030)

1.2.3 Global Anti Allergy Medicine Sales Price (2019-2030)

1.3 Anti Allergy Medicine Market Trends & Drivers

1.3.1 Anti Allergy Medicine Industry Trends

1.3.2 Anti Allergy Medicine Market Drivers & Opportunity

1.3.3 Anti Allergy Medicine Market Challenges

1.3.4 Anti Allergy Medicine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti Allergy Medicine Players Revenue Ranking (2023)

2.2 Global Anti Allergy Medicine Revenue by Company (2019-2024)

2.3 Global Anti Allergy Medicine Players Sales Volume Ranking (2023)

2.4 Global Anti Allergy Medicine Sales Volume by Company Players (2019-2024)

2.5 Global Anti Allergy Medicine Average Price by Company (2019-2024)

2.6 Key Manufacturers Anti Allergy Medicine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anti Allergy Medicine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anti Allergy Medicine

2.9 Anti Allergy Medicine Market Competitive Analysis

2.9.1 Anti Allergy Medicine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anti Allergy Medicine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Allergy Medicine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antihistamines

3.1.2 Anaphylaxis Mediator Blocker Drugs

3.1.3 Calcium Drugs

3.1.4 Immunosuppressant Drugs

3.2 Global Anti Allergy Medicine Sales Value by Type

3.2.1 Global Anti Allergy Medicine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti Allergy Medicine Sales Value, by Type (2019-2030)

3.2.3 Global Anti Allergy Medicine Sales Value, by Type (%) (2019-2030)

3.3 Global Anti Allergy Medicine Sales Volume by Type

3.3.1 Global Anti Allergy Medicine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anti Allergy Medicine Sales Volume, by Type (2019-2030)

3.3.3 Global Anti Allergy Medicine Sales Volume, by Type (%) (2019-2030)

3.4 Global Anti Allergy Medicine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Online Pharmacy

4.1.2 Hospital

4.1.3 Offline Pharmacy

4.1.4 Clinic

4.1.5 Others

4.2 Global Anti Allergy Medicine Sales Value by Application

4.2.1 Global Anti Allergy Medicine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti Allergy Medicine Sales Value, by Application (2019-2030)

4.2.3 Global Anti Allergy Medicine Sales Value, by Application (%) (2019-2030)

4.3 Global Anti Allergy Medicine Sales Volume by Application

4.3.1 Global Anti Allergy Medicine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anti Allergy Medicine Sales Volume, by Application (2019-2030)

4.3.3 Global Anti Allergy Medicine Sales Volume, by Application (%) (2019-2030)

4.4 Global Anti Allergy Medicine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anti Allergy Medicine Sales Value by Region

5.1.1 Global Anti Allergy Medicine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti Allergy Medicine Sales Value by Region (2019-2024)

5.1.3 Global Anti Allergy Medicine Sales Value by Region (2025-2030)

5.1.4 Global Anti Allergy Medicine Sales Value by Region (%), (2019-2030)

5.2 Global Anti Allergy Medicine Sales Volume by Region

5.2.1 Global Anti Allergy Medicine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anti Allergy Medicine Sales Volume by Region (2019-2024)

5.2.3 Global Anti Allergy Medicine Sales Volume by Region (2025-2030)

5.2.4 Global Anti Allergy Medicine Sales Volume by Region (%), (2019-2030)

5.3 Global Anti Allergy Medicine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anti Allergy Medicine Sales Value, 2019-2030

5.4.2 North America Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anti Allergy Medicine Sales Value, 2019-2030

5.5.2 Europe Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anti Allergy Medicine Sales Value, 2019-2030

5.6.2 Asia Pacific Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anti Allergy Medicine Sales Value, 2019-2030

5.7.2 South America Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anti Allergy Medicine Sales Value, 2019-2030

5.8.2 Middle East & Africa Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti Allergy Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti Allergy Medicine Sales Value

6.2.1 Key Countries/Regions Anti Allergy Medicine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anti Allergy Medicine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anti Allergy Medicine Sales Value, 2019-2030

6.3.2 United States Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti Allergy Medicine Sales Value, 2019-2030

6.4.2 Europe Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti Allergy Medicine Sales Value, 2019-2030

6.5.2 China Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti Allergy Medicine Sales Value, 2019-2030

6.6.2 Japan Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti Allergy Medicine Sales Value, 2019-2030

6.7.2 South Korea Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti Allergy Medicine Sales Value, 2019-2030

6.8.2 Southeast Asia Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti Allergy Medicine Sales Value, 2019-2030

6.9.2 India Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti Allergy Medicine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Anti Allergy Medicine Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Bayer Corp

7.2.1 Bayer Corp Company Information

7.2.2 Bayer Corp Introduction and Business Overview

7.2.3 Bayer Corp Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer Corp Anti Allergy Medicine Product Offerings

7.2.5 Bayer Corp Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Anti Allergy Medicine Product Offerings

7.3.5 Sanofi Recent Development

7.4 Weefsel Pharma

7.4.1 Weefsel Pharma Company Information

7.4.2 Weefsel Pharma Introduction and Business Overview

7.4.3 Weefsel Pharma Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Weefsel Pharma Anti Allergy Medicine Product Offerings

7.4.5 Weefsel Pharma Recent Development

7.5 Arlak Biotech

7.5.1 Arlak Biotech Company Information

7.5.2 Arlak Biotech Introduction and Business Overview

7.5.3 Arlak Biotech Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Arlak Biotech Anti Allergy Medicine Product Offerings

7.5.5 Arlak Biotech Recent Development

7.6 Hetero Healthcare

7.6.1 Hetero Healthcare Company Information

7.6.2 Hetero Healthcare Introduction and Business Overview

7.6.3 Hetero Healthcare Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Hetero Healthcare Anti Allergy Medicine Product Offerings

7.6.5 Hetero Healthcare Recent Development

7.7 Pharma Franchise

7.7.1 Pharma Franchise Company Information

7.7.2 Pharma Franchise Introduction and Business Overview

7.7.3 Pharma Franchise Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Pharma Franchise Anti Allergy Medicine Product Offerings

7.7.5 Pharma Franchise Recent Development

7.8 Nutra Respiro

7.8.1 Nutra Respiro Company Information

7.8.2 Nutra Respiro Introduction and Business Overview

7.8.3 Nutra Respiro Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Nutra Respiro Anti Allergy Medicine Product Offerings

7.8.5 Nutra Respiro Recent Development

7.9 Aden Healthcare

7.9.1 Aden Healthcare Company Information

7.9.2 Aden Healthcare Introduction and Business Overview

7.9.3 Aden Healthcare Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Aden Healthcare Anti Allergy Medicine Product Offerings

7.9.5 Aden Healthcare Recent Development

7.10 Stallergenes Greer

7.10.1 Stallergenes Greer Company Information

7.10.2 Stallergenes Greer Introduction and Business Overview

7.10.3 Stallergenes Greer Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Stallergenes Greer Anti Allergy Medicine Product Offerings

7.10.5 Stallergenes Greer Recent Development

7.11 GSK

7.11.1 GSK Company Information

7.11.2 GSK Introduction and Business Overview

7.11.3 GSK Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 GSK Anti Allergy Medicine Product Offerings

7.11.5 GSK Recent Development

7.12 Hikma Pharmaceuticals

7.12.1 Hikma Pharmaceuticals Company Information

7.12.2 Hikma Pharmaceuticals Introduction and Business Overview

7.12.3 Hikma Pharmaceuticals Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Hikma Pharmaceuticals Anti Allergy Medicine Product Offerings

7.12.5 Hikma Pharmaceuticals Recent Development

7.13 Med Globe Therapeutics Limited

7.13.1 Med Globe Therapeutics Limited Company Information

7.13.2 Med Globe Therapeutics Limited Introduction and Business Overview

7.13.3 Med Globe Therapeutics Limited Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Med Globe Therapeutics Limited Anti Allergy Medicine Product Offerings

7.13.5 Med Globe Therapeutics Limited Recent Development

7.14 Taiho Pharmaceutical

7.14.1 Taiho Pharmaceutical Company Information

7.14.2 Taiho Pharmaceutical Introduction and Business Overview

7.14.3 Taiho Pharmaceutical Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Taiho Pharmaceutical Anti Allergy Medicine Product Offerings

7.14.5 Taiho Pharmaceutical Recent Development

7.15 Regeneron Pharmaceuticals

7.15.1 Regeneron Pharmaceuticals Company Information

7.15.2 Regeneron Pharmaceuticals Introduction and Business Overview

7.15.3 Regeneron Pharmaceuticals Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Regeneron Pharmaceuticals Anti Allergy Medicine Product Offerings

7.15.5 Regeneron Pharmaceuticals Recent Development

7.16 Glenmark

7.16.1 Glenmark Company Information

7.16.2 Glenmark Introduction and Business Overview

7.16.3 Glenmark Anti Allergy Medicine Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Glenmark Anti Allergy Medicine Product Offerings

7.16.5 Glenmark Recent Development

8 Industry Chain Analysis

8.1 Anti Allergy Medicine Industrial Chain

8.2 Anti Allergy Medicine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti Allergy Medicine Sales Model

8.5.2 Sales Channel

8.5.3 Anti Allergy Medicine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Hikma Pharmaceuticals

Med Globe Therapeutics Limited

Taiho Pharmaceutical

Regeneron Pharmaceuticals

Glenmark

Pharma Franchise

Nutra Respiro

List of Tables

Table 1. Anti Allergy Medicine Market Trends

Table 2. Anti Allergy Medicine Market Drivers & Opportunity

Table 3. Anti Allergy Medicine Market Challenges

Table 4. Anti Allergy Medicine Market Restraints

Table 5. Global Anti Allergy Medicine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti Allergy Medicine Revenue Market Share by Company (2019-2024)

Table 7. Global Anti Allergy Medicine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Anti Allergy Medicine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anti Allergy Medicine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Anti Allergy Medicine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anti Allergy Medicine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anti Allergy Medicine

Table 13. Global Anti Allergy Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Allergy Medicine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti Allergy Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anti Allergy Medicine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anti Allergy Medicine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anti Allergy Medicine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anti Allergy Medicine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anti Allergy Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Anti Allergy Medicine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Anti Allergy Medicine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Anti Allergy Medicine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anti Allergy Medicine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anti Allergy Medicine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Anti Allergy Medicine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Anti Allergy Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anti Allergy Medicine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anti Allergy Medicine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anti Allergy Medicine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anti Allergy Medicine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anti Allergy Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Anti Allergy Medicine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Anti Allergy Medicine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Anti Allergy Medicine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anti Allergy Medicine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anti Allergy Medicine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Anti Allergy Medicine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Anti Allergy Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anti Allergy Medicine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anti Allergy Medicine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anti Allergy Medicine Sales Value by Region (2019-2024) & (%)

Table 44. Global Anti Allergy Medicine Sales Value by Region (2025-2030) & (%)

Table 45. Global Anti Allergy Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Anti Allergy Medicine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Anti Allergy Medicine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Anti Allergy Medicine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anti Allergy Medicine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anti Allergy Medicine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Anti Allergy Medicine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Anti Allergy Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anti Allergy Medicine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anti Allergy Medicine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anti Allergy Medicine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Anti Allergy Medicine Sales Volume, (2025-2030) & (K Units)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Anti Allergy Medicine Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Bayer Corp Company Information

Table 63. Bayer Corp Introduction and Business Overview

Table 64. Bayer Corp Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Bayer Corp Anti Allergy Medicine Product Offerings

Table 66. Bayer Corp Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Anti Allergy Medicine Product Offerings

Table 71. Sanofi Recent Development

Table 72. Weefsel Pharma Company Information

Table 73. Weefsel Pharma Introduction and Business Overview

Table 74. Weefsel Pharma Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Weefsel Pharma Anti Allergy Medicine Product Offerings

Table 76. Weefsel Pharma Recent Development

Table 77. Arlak Biotech Company Information

Table 78. Arlak Biotech Introduction and Business Overview

Table 79. Arlak Biotech Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Arlak Biotech Anti Allergy Medicine Product Offerings

Table 81. Arlak Biotech Recent Development

Table 82. Hetero Healthcare Company Information

Table 83. Hetero Healthcare Introduction and Business Overview

Table 84. Hetero Healthcare Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Hetero Healthcare Anti Allergy Medicine Product Offerings

Table 86. Hetero Healthcare Recent Development

Table 87. Pharma Franchise Company Information

Table 88. Pharma Franchise Introduction and Business Overview

Table 89. Pharma Franchise Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Pharma Franchise Anti Allergy Medicine Product Offerings

Table 91. Pharma Franchise Recent Development

Table 92. Nutra Respiro Company Information

Table 93. Nutra Respiro Introduction and Business Overview

Table 94. Nutra Respiro Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Nutra Respiro Anti Allergy Medicine Product Offerings

Table 96. Nutra Respiro Recent Development

Table 97. Aden Healthcare Company Information

Table 98. Aden Healthcare Introduction and Business Overview

Table 99. Aden Healthcare Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Aden Healthcare Anti Allergy Medicine Product Offerings

Table 101. Aden Healthcare Recent Development

Table 102. Stallergenes Greer Company Information

Table 103. Stallergenes Greer Introduction and Business Overview

Table 104. Stallergenes Greer Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Stallergenes Greer Anti Allergy Medicine Product Offerings

Table 106. Stallergenes Greer Recent Development

Table 107. GSK Company Information

Table 108. GSK Introduction and Business Overview

Table 109. GSK Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. GSK Anti Allergy Medicine Product Offerings

Table 111. GSK Recent Development

Table 112. Hikma Pharmaceuticals Company Information

Table 113. Hikma Pharmaceuticals Introduction and Business Overview

Table 114. Hikma Pharmaceuticals Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Hikma Pharmaceuticals Anti Allergy Medicine Product Offerings

Table 116. Hikma Pharmaceuticals Recent Development

Table 117. Med Globe Therapeutics Limited Company Information

Table 118. Med Globe Therapeutics Limited Introduction and Business Overview

Table 119. Med Globe Therapeutics Limited Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Med Globe Therapeutics Limited Anti Allergy Medicine Product Offerings

Table 121. Med Globe Therapeutics Limited Recent Development

Table 122. Taiho Pharmaceutical Company Information

Table 123. Taiho Pharmaceutical Introduction and Business Overview

Table 124. Taiho Pharmaceutical Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Taiho Pharmaceutical Anti Allergy Medicine Product Offerings

Table 126. Taiho Pharmaceutical Recent Development

Table 127. Regeneron Pharmaceuticals Company Information

Table 128. Regeneron Pharmaceuticals Introduction and Business Overview

Table 129. Regeneron Pharmaceuticals Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Regeneron Pharmaceuticals Anti Allergy Medicine Product Offerings

Table 131. Regeneron Pharmaceuticals Recent Development

Table 132. Glenmark Company Information

Table 133. Glenmark Introduction and Business Overview

Table 134. Glenmark Anti Allergy Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Glenmark Anti Allergy Medicine Product Offerings

Table 136. Glenmark Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Anti Allergy Medicine Downstream Customers

Table 140. Anti Allergy Medicine Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti Allergy Medicine Product Picture

Figure 2. Global Anti Allergy Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anti Allergy Medicine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Anti Allergy Medicine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Anti Allergy Medicine Report Years Considered

Figure 7. Global Anti Allergy Medicine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anti Allergy Medicine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti Allergy Medicine Revenue in 2023

Figure 10. Anti Allergy Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Antihistamines Picture

Figure 12. Anaphylaxis Mediator Blocker Drugs Picture

Figure 13. Calcium Drugs Picture

Figure 14. Immunosuppressant Drugs Picture

Figure 15. Global Anti Allergy Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Anti Allergy Medicine Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Anti Allergy Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Anti Allergy Medicine Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Anti Allergy Medicine Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Online Pharmacy

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Offline Pharmacy

Figure 23. Product Picture of Clinic

Figure 24. Product Picture of Others

Figure 25. Global Anti Allergy Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Anti Allergy Medicine Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Anti Allergy Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Anti Allergy Medicine Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Anti Allergy Medicine Price by Application (2019-2030) & (US$/Unit)

Figure 30. North America Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Anti Allergy Medicine Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Anti Allergy Medicine Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Anti Allergy Medicine Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Anti Allergy Medicine Sales Volume (%), (2019-2030)

Figure 42. United States Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 48. China Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 50. China Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 60. India Anti Allergy Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Anti Allergy Medicine Sales Value by Type (%), 2023 VS 2030

Figure 62. India Anti Allergy Medicine Sales Value by Application (%), 2023 VS 2030

Figure 63. Anti Allergy Medicine Industrial Chain

Figure 64. Anti Allergy Medicine Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions